Literature DB >> 17953251

Hypogonadotropic hypogonadism in a patient with morbid obesity.

Miguel Angel Mollar Puchades1, Rosa Cámara Gómez, Maria Isabel del Olmo García, José Luis Ponce Marco, Raquel Segovia Portolés, Pablo Abellán Galiana, Francisco Piñón Sellés.   

Abstract

Obesity has recently become one of the most important public health problems. It is associated with a high rate of mortality, mainly because of cardiovascular disease, and can cause hormonal abnormalities such as hypogonadotropic hypogonadism. Weight loss is very beneficial for obese patients, because it results in improvement or even normalization of these conditions. In this report, we describe a morbidly obese patient with hypogonadotropic hypogonadism, which was probably caused by hyperprolactinemia and exacerbated by obesity-induced hormonal imbalances. After medical treatment for hyperprolactinemia and bariatric surgery, the patient's hormonal status became normal. Although morbid obesity can cause hypogonadotropic hypogonadism in men, the differential diagnosis should include other potential causes of hypogonadism if free testosterone levels are below normal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17953251     DOI: 10.1007/s11695-007-9190-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  20 in total

Review 1.  Diagnosis and treatment of pituitary adenomas.

Authors:  P Chanson; S Salenave
Journal:  Minerva Endocrinol       Date:  2004-12       Impact factor: 2.184

2.  Reversal of Hair Loss following Vertical Gastroplasty when Treated with Zinc Sulphate.

Authors: 
Journal:  Obes Surg       Date:  1996-02       Impact factor: 4.129

3.  Decrease in circulating glucose, insulin and leptin levels and improvement in insulin resistance at 1 and 3 months after gastric bypass.

Authors:  Adriana Pelegrino Pinho Ramos; Márcia Regina Azevedo de Abreu; Regina Célia Vendramini; Iguatemy Lourenço Brunetti; Maria Teresa Pepato
Journal:  Obes Surg       Date:  2006-10       Impact factor: 4.129

4.  Changes in BMI modulate age-associated changes in sex hormone binding globulin and total testosterone, but not bioavailable testosterone in young adult men: the CARDIA Male Hormone Study.

Authors:  S M Gapstur; P Kopp; P H Gann; B C-H Chiu; L A Colangelo; K Liu
Journal:  Int J Obes (Lond)       Date:  2006-09-12       Impact factor: 5.095

5.  Relationship of androgens to insulin resistance and chronic inflammation in morbidly obese premenopausal women: studies before and after vertical banded gastroplasty.

Authors:  Hans-Peter Kopp; Katharina Krzyzanowska; Gerit-Holger Schernthaner; Stefan Kriwanek; Guntram Schernthaner
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

6.  Some hormonal changes before and after vertical banded gastroplasty for severe obesity.

Authors:  Y I Yashkov; L I Vinnitsky; M V Poroykova; N T Vorobyova
Journal:  Obes Surg       Date:  2000-02       Impact factor: 4.129

7.  Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA-S levels.

Authors:  Edward Ram; Tali Vishne; Dror Diker; Irit Gal-Ad; Rachel Maayan; Igor Lerner; Zeev Dreznik; Dan Seror; Pnina Vardi; Abraham Weizman
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

8.  Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat.

Authors:  N Lima; H Cavaliere; M Knobel; A Halpern; G Medeiros-Neto
Journal:  Int J Obes Relat Metab Disord       Date:  2000-11

9.  The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.

Authors:  Mary P Gillam; Stewart Middler; Daniel J Freed; Mark E Molitch
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

Review 10.  Endocrinological aspects of obesity.

Authors:  R Jung
Journal:  Clin Endocrinol Metab       Date:  1984-11
View more
  1 in total

1.  Circulating free testosterone in obese men after bariatric surgery increases in parallel with insulin sensitivity.

Authors:  J I Botella-Carretero; J A Balsa; J M Gómez-Martin; R Peromingo; L Huerta; M Carrasco; F Arrieta; I Zamarron; A Martin-Hidalgo; C Vazquez
Journal:  J Endocrinol Invest       Date:  2012-06-25       Impact factor: 5.467

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.